{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T21:41:01Z","timestamp":1792964461296,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["SP\/12\/10\/29922"],"award-info":[{"award-number":["SP\/12\/10\/29922"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Research Training Fellowship","award":["MR\/V007017\/1"],"award-info":[{"award-number":["MR\/V007017\/1"]}]},{"name":"Clinical Research Training Fellowship","award":["MR\/V007254\/1"],"award-info":[{"award-number":["MR\/V007254\/1"]}]},{"name":"UK Medical Research Council and by a Research Excellence Award","award":["RE\/18\/5\/34216"],"award-info":[{"award-number":["RE\/18\/5\/34216"]}],"id":[{"id":"https:\/\/ror.org\/03x94j517","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Data Research UK","id":[{"id":"https:\/\/ror.org\/04rtjaj74","id-type":"ROR","asserted-by":"crossref"}]},{"name":"HDR UK Ltd","award":["HDR-5012"],"award-info":[{"award-number":["HDR-5012"]}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office of the Scottish Government Health and Social Care Directorates","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010756","name":"Health and Social Care Research and Development Division","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010756","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001626","name":"Public Health Agency","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001626","id-type":"DOI","asserted-by":"crossref"}]},{"name":"British Heart Foundation, and the Wellcome Trust","id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Butler BHF Senior Clinical Research Fellowship","award":["FS\/16\/14\/32023"],"award-info":[{"award-number":["FS\/16\/14\/32023"]}]},{"name":"Programme Grant","award":["RG\/20\/10\/34966"],"award-info":[{"award-number":["RG\/20\/10\/34966"]}]},{"name":"Research Excellence Award","award":["RE\/18\/5\/34216"],"award-info":[{"award-number":["RE\/18\/5\/34216"]}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Starter Grant for Clinical Lecturers by the Academy of Medical Sciences","award":["SGL021\/1075"],"award-info":[{"award-number":["SGL021\/1075"]}],"id":[{"id":"https:\/\/ror.org\/00c489v88","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Whilst the risk factors for type 1 myocardial infarction due to atherosclerotic plaque rupture and thrombosis are established, our understanding of the factors that predispose to type 2 myocardial infarction during acute illness is still emerging. Our aim was to evaluate and compare the risk factors for type 1 and type 2 myocardial infarction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We conducted a secondary analysis of a multi-centre randomized trial population of 48 282 consecutive patients attending hospital with suspected acute coronary syndrome. The diagnosis of myocardial infarction during the index presentation and all subsequent reattendances was adjudicated according to the Universal Definition of Myocardial Infarction. Cox regression was used to identify predictors of future type 1 and type 2 myocardial infarction during a 1-year follow-up period. Within 1 year, 1331 patients had a subsequent myocardial infarction, with 924 and 407 adjudicated as type 1 and type 2 myocardial infarction, respectively. Risk factors for type 1 and type 2 myocardial infarction were similar, with age, hyperlipidaemia, diabetes, abnormal renal function, and known coronary disease predictors for both (P &amp;lt; 0.05 for all). Whilst women accounted for a greater proportion of patients with type 2 as compared to type 1 myocardial infarction, after adjustment for other risk factors, sex was not a predictor of type 2 myocardial events [adjusted hazard ratio (aHR) 0.82, 95% confidence interval (CI) 0.66\u20131.01]. The strongest predictor of type 2 myocardial infarction was a prior history of type 2 events (aHR 6.18, 95% CI 4.70\u20138.12).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Risk factors for coronary disease that are associated with type 1 myocardial infarction are also important predictors of type 2 events during acute illness. Treatment of these risk factors may reduce future risk of both type 1 and type 2 myocardial infarction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab581","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T07:08:16Z","timestamp":1628665696000},"page":"127-135","source":"Crossref","is-referenced-by-count":99,"title":["Risk factors for type 1 and type 2 myocardial infarction"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-453X","authenticated-orcid":false,"given":"Ryan","family":"Wereski","sequence":"first","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh , Chancellors Building, 49 Little France Crescent, Edinburgh EH16 4SA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1591-1352","authenticated-orcid":false,"given":"Dorien M","family":"Kimenai","sequence":"additional","affiliation":[{"name":"Usher Institute, University of Edinburgh , Edinburgh, NINE, 9 Little France Road, Edinburgh BioQuarter, Edinburgh EH16 4UX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5530-527X","authenticated-orcid":false,"given":"Anda","family":"Bularga","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh , Chancellors Building, 49 Little France Crescent, Edinburgh EH16 4SA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7379-5439","authenticated-orcid":false,"given":"Caelan","family":"Taggart","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh , Chancellors Building, 49 Little France Crescent, Edinburgh EH16 4SA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4866-2049","authenticated-orcid":false,"given":"David J","family":"Lowe","sequence":"additional","affiliation":[{"name":"University of Glasgow, School of Medicine , Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-7991","authenticated-orcid":false,"given":"Nicholas L","family":"Mills","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh , Chancellors Building, 49 Little France Crescent, Edinburgh EH16 4SA, UK"},{"name":"Usher Institute, University of Edinburgh , Edinburgh, NINE, 9 Little France Road, Edinburgh BioQuarter, Edinburgh EH16 4UX, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Chapman","sequence":"additional","affiliation":[{"name":"BHF Centre for Cardiovascular Science, University of Edinburgh , Chancellors Building, 49 Little France Crescent, Edinburgh EH16 4SA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"2022102514550575200_ehab581-B1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102514550575200_ehab581-B2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/heartjnl-2016-309530","article-title":"Assessment and classification of patients with myocardial injury and infarction in clinical practice","volume":"103","author":"Chapman","year":"2017","journal-title":"Heart"},{"key":"2022102514550575200_ehab581-B3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1373\/clinchem.2016.255521","article-title":"Myocardial infarction type 2 and myocardial injury","volume":"63","author":"Sandoval","year":"2017","journal-title":"Clin Chem"},{"key":"2022102514550575200_ehab581-B4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"2022102514550575200_ehab581-B5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"2022102514550575200_ehab581-B6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/CIRCULATIONAHA.119.042960","article-title":"High-sensitivity cardiac troponin and the universal definition of myocardial infarction","volume":"141","author":"Chapman","year":"2020","journal-title":"Circulation"},{"key":"2022102514550575200_ehab581-B7","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.117.031806","article-title":"Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury","volume":"137","author":"Chapman","year":"2018","journal-title":"Circulation"},{"key":"2022102514550575200_ehab581-B8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/heartjnl-2014-306093","article-title":"Type 2 myocardial infarction in clinical practice","volume":"101","author":"Baron","year":"2015","journal-title":"Heart"},{"key":"2022102514550575200_ehab581-B9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.amjmed.2013.12.020","article-title":"Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort","volume":"127","author":"Saaby","year":"2014","journal-title":"Am J Med"},{"key":"2022102514550575200_ehab581-B10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.119.043100","article-title":"Incidence, trends, and outcomes of type 2 myocardial infarction in a community cohort","volume":"141","author":"Raphael","year":"2020","journal-title":"Circulation"},{"key":"2022102514550575200_ehab581-B11","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1093\/eurheartj\/ehx457","article-title":"Discrimination of patients with type 2 myocardial infarction","volume":"38","author":"Neumann","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102514550575200_ehab581-B12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCULATIONAHA.116.023052","article-title":"Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography","volume":"135","author":"Gaggin","year":"2017","journal-title":"Circulation"},{"key":"2022102514550575200_ehab581-B13","doi-asserted-by":"crossref","first-page":"446.e5","DOI":"10.1016\/j.amjmed.2015.11.006","article-title":"Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins","volume":"129","author":"Sarkisian","year":"2016","journal-title":"Am J Med"},{"key":"2022102514550575200_ehab581-B14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jacc.2017.07.784","article-title":"The many faces of type 2 myocardial infarction","volume":"70","author":"Januzzi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102514550575200_ehab581-B15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)31923-8","article-title":"High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial","volume":"392","author":"Shah","year":"2018","journal-title":"Lancet"},{"key":"2022102514550575200_ehab581-B16","doi-asserted-by":"crossref","first-page":"g7873","DOI":"10.1136\/bmj.g7873","article-title":"High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study","volume":"350","author":"Shah","year":"2015","journal-title":"BMJ"},{"key":"2022102514550575200_ehab581-B17","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1093\/eurheartj\/ehu189","article-title":"High-sensitivity troponin i concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis","volume":"35","author":"Chin","year":"2014","journal-title":"Eur Heart J"},{"key":"2022102514550575200_ehab581-B18","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Writing Group on behalf of the Joint ESC\/ACCF\/AHA\/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"2022102514550575200_ehab581-B19","author":"Healthcare Improvement Scotland","year":"2013"},{"key":"2022102514550575200_ehab581-B20","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.amjmed.2017.05.049","article-title":"Type 1 and 2 myocardial infarction and myocardial injury: clinical transition to high-sensitivity cardiac troponin I","volume":"130","author":"Sandoval","year":"2017","journal-title":"Am J Med"},{"key":"2022102514550575200_ehab581-B21","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jacc.2019.12.052","article-title":"Cardiovascular mortality after type 1 and type 2 myocardial infarction in young adults","volume":"75","author":"Singh","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102514550575200_ehab581-B22","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2022102514550575200_ehab581-B23","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jacc.2020.12.034","article-title":"Patient characteristics and clinical outcomes of type 1 versus type 2 myocardial infarction","volume":"77","author":"Mccarthy","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2022102514550575200_ehab581-B24","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.amjmed.2013.02.029","article-title":"Classification of myocardial infarction: frequency and features of type 2 myocardial infarction","volume":"126","author":"Saaby","year":"2013","journal-title":"Am J Med"},{"key":"2022102514550575200_ehab581-B25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.amjmed.2015.11.035","article-title":"Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction","volume":"129","author":"Baron","year":"2016","journal-title":"Am J Med"},{"key":"2022102514550575200_ehab581-B26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.amjcard.2009.03.003","article-title":"Frequency of elevated troponin I and diagnosis of acute myocardial infarction","volume":"104","author":"Javed","year":"2009","journal-title":"Am J Cardiol"},{"key":"2022102514550575200_ehab581-B27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.amjmed.2017.11.043","article-title":"Different causes of death in patients with myocardial infarction type 1, type 2, and myocardial injury","volume":"131","author":"Lambrecht","year":"2018","journal-title":"Am J Med"},{"key":"2022102514550575200_ehab581-B28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/clinchem\/hvaa189","article-title":"Type 2 myocardial infarction: evolving approaches to diagnosis and risk-stratification","volume":"67","author":"Chapman","year":"2021","journal-title":"Clin Chem"},{"key":"2022102514550575200_ehab581-B29","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/eurheartj\/ehaa375","article-title":"Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction","volume":"42","author":"Hung","year":"2021","journal-title":"Eur Heart J"},{"key":"2022102514550575200_ehab581-B30","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.3390\/jcm10112331","article-title":"Diagnosis, investigation and management of patients with acute and chronic myocardial injury","volume":"10","author":"Taggart","year":"2021","journal-title":"J Clin Med"},{"key":"2022102514550575200_ehab581-B31","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1093\/eurheartj\/ehz299","article-title":"Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial","volume":"40","author":"White","year":"2019","journal-title":"Eur Heart J"},{"key":"2022102514550575200_ehab581-B32","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.119.039996","article-title":"Dapagliflozin and cardiovascular outcomes in patients with type 2 diabetes mellitus and previous myocardial infarction: subanalysis from the DECLARE-TIMI 58","volume":"139","author":"Furtado","year":"2019","journal-title":"Trial. Circulation"},{"key":"2022102514550575200_ehab581-B33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ahj.2018.09.016","article-title":"The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): a randomized trial design","volume":"208","author":"Lambrakis","year":"2019","journal-title":"Am Heart J"},{"key":"2022102514550575200_ehab581-B34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(20)30543-2","article-title":"Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"396","author":"Walli-Attaei","year":"2020","journal-title":"Lancet"},{"key":"2022102514550575200_ehab581-B35","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2021-319118","article-title":"Sex differences in investigations and outcomes among patients with type 2 myocardial infarction","author":"Kimenai","year":"2021","journal-title":"Heart"},{"key":"2022102514550575200_ehab581-B36","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1373\/clinchem.2018.286781","article-title":"Sex-specific versus overall clinical decision limits for cardiac troponin I and T for the diagnosis of acute myocardial infarction: a systematic review","volume":"64","author":"Kimenai","year":"2018","journal-title":"Clin Chem"},{"key":"2022102514550575200_ehab581-B37","doi-asserted-by":"crossref","first-page":"j4788","DOI":"10.1136\/bmj.j4788","article-title":"Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study","volume":"359","author":"Shah","year":"2017","journal-title":"BMJ"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/2\/127\/46626157\/ehab581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/2\/127\/46626157\/ehab581.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T13:45:05Z","timestamp":1666705505000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/2\/127\/6357312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,8,25]]},"published-print":{"date-parts":[[2022,1,13]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab581","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,7]]},"published":{"date-parts":[[2021,8,25]]}}}